3:01

Due to risk of serious liver injury, FDA restricts use of obeticholic acid (Ocaliva) in primary b...

20:43

VIRTUAL PRESS CONFERENCE: FDA’s Proposed Rule on Reducing Nicotine Levels – 1/15/2025

17:02

CDER BIMO: Electronic Submission Requirements for New Drug and Biologic Licensing Applications

19:15

MEDIA CALL: Front of Package Nutrition Labels – 1/14/2025

1:42:25

FDA Clinical Investigator Training Course (CITC) 2024 – Day One – Session Two

7:49:20

January 10, 2025 Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) Meeting

1:04:05

Cervical Cancer Treatment Innovation: A Collaborative Discussion

3:01

FDA D.I.S.C.O. Burst Edition: FDA approval of Bizengri (zenocutuzumab-zbco) for Treatment of adul...